Cystic fibrosis-related diabetes and lung disease: an update
Open Access
- 17 February 2021
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 30 (159) , 200293
Abstract
The development of cystic fibrosis-related diabetes (CFRD) often leads to poorer outcomes in patients with cystic fibrosis including increases in pulmonary exacerbations, poorer lung function and early mortality. This review highlights the many factors contributing to the clinical decline seen in patients diagnosed with CFRD, highlighting the important role of nutrition, the direct effect of hyperglycaemia on the lungs, the immunomodulatory effects of high glucose levels and the potential role of genetic modifiers in CFRD.Keywords
This publication has 130 references indexed in Scilit:
- Elevated Paracellular Glucose Flux across Cystic Fibrosis Airway Epithelial Monolayers Is an Important Factor for Pseudomonas aeruginosa GrowthPLOS ONE, 2013
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lungNature, 2012
- Decade-long bacterial community dynamics in cystic fibrosis airwaysProceedings of the National Academy of Sciences, 2012
- High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitusImmunobiology, 2011
- Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional studyBMC Pulmonary Medicine, 2010
- Diabetes as a Determinant of Mortality in Cystic FibrosisDiabetes Care, 2009
- Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammationAnnals of Medicine, 2009
- Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 DiabetesDiabetes Care, 2008
- Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and AdipocytesPLOS ONE, 2006